The company utilizes third-party contract manufacturers for the formulation, manufacturing, and supply of its drug product, including a primary manufacturer for the active ingredient gedatolisib. Additional third parties handle packaging, storage, and distribution during clinical trials. The company plans to engage a third-party logistics provider (3PL) for commercial distribution contingent upon FDA approval. The limited number of manufacturers and the requirement for FDA approval of any replacements present risks such as difficulties in securing manufacturers on acceptable terms, challenges related to manufacturing volume and quality, contract performance issues, and regulatory non-compliance. Shipping carriers are essential for timely delivery, and any performance problems, price increases, or service interruptions could negatively impact operations and reputation. There are few providers offering overnight nationwide transport services, and maintaining agreements on acceptable terms is uncertain.
Celcuity Inc's Comment on Supply Chain
The company utilizes third-party contract manufacturers for the formulation, manufacturing, and supply of its drug product, including a primary manufacturer for the active ingredient gedatolisib. Additional third parties handle packaging, storage, and distribution during clinical trials. The company plans to engage a third-party logistics provider (3PL) for commercial distribution contingent upon FDA approval. The limited number of manufacturers and the requirement for FDA approval of any replacements present risks such as difficulties in securing manufacturers on acceptable terms, challenges related to manufacturing volume and quality, contract performance issues, and regulatory non-compliance. Shipping carriers are essential for timely delivery, and any performance problems, price increases, or service interruptions could negatively impact operations and reputation. There are few providers offering overnight nationwide transport services, and maintaining agreements on acceptable terms is uncertain.
Sources:
Celcuity Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Celcuity Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
